$214M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | KLAC Kla Corp | 178,471 | +797.6% | $54M | 25.2% |
| 2 | BMY Bristol-Myers Squibb Co | 297,243 | −2.9% | $17M | 8.0% |
| 3 | LRCX Lam Research Corp | 35,000 | −2.8% | $15M | 7.1% |
| 4 | NTLA Intellia Therapeutics Inc | 385,900 | −13.4% | $7M | 3.2% |
| 5 | SLDB Solid Biosciences Inc | 666,196 | +6.4% | $7M | 3.1% |
| 6 | BDSX Biodesix Inc | 286,804 | +0.0% | $6M | 3.0% |
| 7 | STOK Stoke Therapeutics Inc | 178,110 | −15.2% | $6M | 2.7% |
| 8 | OVV Ovintiv Inc | 107,500 | +0.0% | $6M | 2.6% |
| 9 | NKTR Nektar Therapeutics | 81,000 | +161.3% | $6M | 2.6% |
| 10 | CORT Corcept Therapeutics Inc | 57,200 | +21.2% | $5M | 2.3% |
| 11 | NBIX Neurocrine Biosciences Inc | 27,190 | +0.0% | $5M | 2.1% |
| 12 | PRTA Prothena Corp Plc | 449,019 | +0.0% | $4M | 2.1% |
| 13 | ACAD Acadia Pharmaceuticals Inc | 171,000 | +0.0% | $4M | 2.0% |
| 14 | PTGX Protagonist Therapeutics Inc | 35,018 | +0.1% | $4M | 2.0% |
| 15 | CMPX Compass Therapeutics Inc | 1.7M | +14.3% | $4M | 1.7% |
| 16 | RLMD Relmada Therapeutics Inc | 408,100 | −0.3% | $3M | 1.3% |
| 17 | ALKS Alkermes Plc | 50,000 | +0.0% | $3M | 1.2% |
| 18 | HALO Halozyme Therapeutics Inc | 33,251 | +229.2% | $3M | 1.2% |
| 19 | CLDX Celldex Therapeutics Inc New | 69,900 | −0.3% | $3M | 1.2% |
| 20 | CYTK Cytokinetics Inc | 30,000 | +0.0% | $3M | 1.2% |
| 21 | OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc | 199,000 | −9.1% | $2M | 1.2% |
| 22 | VERA Vera Therapeutics Inc | 57,758 | +31.3% | $2M | 1.2% |
| 23 | UTHR United Therapeutics Corp Del | 4,506 | +0.1% | $2M | 1.1% |
| 24 | ZBIO Zenas Biopharma Inc | 93,601 | +33.7% | $2M | 1.1% |
| 25 | UNIQURE NV Uniqure Nv | 50,697 | −49.7% | $2M | 1.1% |
| 26 | PACIFIC BIOSCIENCES CALIF IN Pacific Biosciences Calif In | 1.4M | −10.0% | $2M | 1.1% |
| 27 | ABIVAX SA Abivax Sa | 17,000 | — | $2M | 1.1% |
| 28 | VIR Vir Biotechnology Inc | 220,000 | — | $2M | 1.0% |
| 29 | BIIB Biogen Inc | 9,000 | +80.0% | $2M | 0.9% |
| 30 | EQT Eqt Corp | 34,619 | +0.0% | $2M | 0.9% |
| 31 | BIOA Bioage Labs Inc | 69,000 | — | $2M | 0.8% |
| 32 | TVTX Travere Therapeutics Inc | 29,000 | −0.7% | $2M | 0.8% |
| 33 | QDEL Quidelortho Corp | 89,377 | +8.3% | $2M | 0.7% |
| 34 | AXSM Axsome Therapeutics Inc. | 6,000 | +0.0% | $1M | 0.7% |
| 35 | FHTX Foghorn Therapeutics Inc | 281,937 | +0.1% | $1M | 0.6% |
| 36 | BCYC Bicycle Therapeutics Plc | 313,616 | −32.4% | $1M | 0.6% |
| 37 | GPCR Structure Therapeutics Inc | 24,000 | −76.0% | $1M | 0.6% |
| 38 | XENE Xenon Pharmaceuticals Inc | 21,032 | +0.2% | $1M | 0.6% |
| 39 | NVO Novo-Nordisk A S | 24,000 | — | $1M | 0.5% |
| 40 | FCX Freeport Mcmoran Inc | 18,035 | −0.0% | $1M | 0.5% |
| 41 | IMNM Immunome Inc | 50,000 | +0.0% | $1M | 0.5% |
| 42 | PHVS Pharvaris N V | 29,847 | +0.0% | $1M | 0.5% |
| 43 | HROW Harrow Inc | 24,000 | +0.0% | $1M | 0.5% |
| 44 | ADAG Adagene Inc | 240,000 | — | $1M | 0.5% |
| 45 | DFTX Definium Therapeutics Inc | 20,000 | — | $940,800 | 0.4% |
| 46 | SLN Silence Therapeutics Plc | 71,218 | — | $781,974 | 0.4% |
| 47 | BBIO Bridgebio Pharma Inc | 8,741 | +0.6% | $651,030 | 0.3% |
| 48 | FDMT 4D Molecular Therapeutics In | 48,505 | — | $645,117 | 0.3% |
| 49 | URGN Urogen Pharma Ltd | 16,487 | — | $606,722 | 0.3% |
| 50 | PHAT Phathom Pharmaceuticals Inc | 55,000 | −71.8% | $596,750 | 0.3% |